Results 101 to 110 of about 13,239 (158)
A phase I / IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis
Myelofibrosis (MF) is a progressive disease characterized by accumulation of extracellular matrix (ECM) in the bone marrow (BM) which impairs normal hematopoiesis.
Pankit Vachhani +22 more
doaj +1 more source
Retraction: Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma.
PLOS ONE Editors
doaj +2 more sources
Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer [PDF]
core +1 more source
Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale
Rob Janssen,1 Emiel FM Wouters,2 Wim Janssens,3 Willeke F Daamen,4 Paul Hagedoorn,5 Hugo AJM de Wit,6 Jef Serré,3 Ghislaine Gayan-Ramirez,3 Frits ME Franssen,2 Niki L Reynaert,2 Jan H von der Thüsen,7 Henderik W Frijlink5 1Department of ...
Janssen R +11 more
doaj
Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations [PDF]
core +1 more source
Elastin haploinsufficiency induces alternative aging processes in the aorta [PDF]
Boyle, Walter A +13 more
core +2 more sources
Expression and localization of Menkes and Wilson copper transporting ATPases in human placenta
Ackland +35 more
core +1 more source

